EcoR1 Capital, LLC, 10% Owner at Adaptimmune Therapeutics PLC (ADAP), sold 125,417,616 shares at $0.10 ($13.2M) on 2025-07-30, disclosed to the SEC on 2025-07-30.
Open-market sale of $13.2M ADAP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.11 | 33,931,740 | $3.7M | 28.2% |
| 2 | $0.11 | 33,931,740 | $3.7M | 28.2% |
| 3 | $0.10 | 2,687,460 | $269K | 2.0% |
| 4 | $0.10 | 27,433,338 | $2.7M | 20.8% |
| 5 | $0.10 | 27,433,338 | $2.7M | 20.8% |
| Total | $0.11 avg |
| 125,417,616 |
| $13.2M |
| 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |
| ITOS | BUY | 2025-05-16 | $51.0M | — | Filing → |